MyFinsight
Home
Compare
Blog
About
BriaCell Therapeutics Corp. (BCTXL)
BriaCell Therapeutics Corp. (BCTXL)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Cash Flow Overview
Change in Cash
-$3,613,587
Free Cash flow
-$22,819,501
Unit: Dollar
Positive Cash Flow Breakdown
Proceeds from the issuance of sh...
Proceeds from short-term investm...
Share-based compensation
Others
Negative Cash Flow Breakdown
Net loss for the period
Purchase of short-term investmen...
Decrease in accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-04-30
Net loss for the period
-22,812,276
Amortization
11,453
Financial income, net
143,204
Depreciation
74,871
Share-based compensation
1,012,749
Share of loss on equity investment
-171,126
Change in fair value of the warrant liability
-265,818
Unrealized gain on investment
137,830
Increase (decrease) in amounts receivable and prepaid expenses
-216,031
Decrease in accounts payable
-1,109,266
Increase in accrued expenses and other payables
721,774
Total cash flow from operating activities
-22,692,452
Purchase of equipment
127,049
Purchase of short-term investments
15,781,000
Proceeds from short-term investments
7,372,473
Equity investment in bc therapeutics
260,000
Total cash flow from investing activities
-8,795,576
Proceeds from the issuance of shares, net of issuance costs
27,874,441
Total cash flow from financing activities
27,874,441
Increase (decrease) in cash and cash equivalents
-3,613,587
Cash and cash equivalents at beginning of the period
10,493,808
Cash and cash equivalents at end of the period
6,880,221
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from the
issuance of shares, net of...
$27,874,441
Total cash flow from
financing activities
$27,874,441
Increase (decrease) in
cash and cash...
-$3,613,587
Canceled cashflow
$27,874,441
Share-based compensation
$1,012,749
Increase in accrued
expenses and other...
$721,774
Share of loss on equity
investment
-$171,126
Depreciation
$74,871
Amortization
$11,453
Proceeds from short-term
investments
$7,372,473
Total cash flow from
operating activities
-$22,692,452
Canceled cashflow
$1,991,973
Total cash flow from
investing activities
-$8,795,576
Canceled cashflow
$7,372,473
Net loss for the
period
-$22,812,276
Decrease in accounts
payable
-$1,109,266
Change in fair value of
the warrant...
-$265,818
Increase (decrease) in
amounts receivable and...
-$216,031
Financial income, net
$143,204
Unrealized gain on
investment
$137,830
Purchase of short-term
investments
$15,781,000
Equity investment in bc
therapeutics
$260,000
Purchase of equipment
$127,049
Buy us a coffee